![]()
|
|
||||||||
(Received for publication, September 19, 1996, and in revised form, April 9, 1997)
From the A human liver carboxylesterase (hCE-2) that
catalyzes the hydrolysis of the benzoyl group of cocaine and the acetyl
groups of 4-methylumbelliferyl acetate, heroin, and
6-monoacetylmorphine was purified from human liver. The purified enzyme
exhibited a single band on SDS-polyacrylamide gel electrophoresis with
a subunit mass of approximately 60 kDa. The native enzyme was
monomeric. The isoelectric point of hCE-2 was approximately 4.9. Treatment with endoglycosidase H caused an increase in electrophoretic
mobility indicating that the liver carboxylesterase was a glycoprotein of the high mannose type. The complete cDNA nucleotide sequence was
determined. The authenticity of the cDNA was confirmed by a perfect
sequence match of 78 amino acids derived from the hCE-2 purified from
human liver. The mature 533-amino acid enzyme encoded by this cDNA
shared highest sequence identity with the rabbit liver carboxylesterase
form 2 (73%) and the hamster liver carboxylesterase AT51p (67%).
Carboxylesterases with high sequence identity to hCE-2 have not been
reported in mouse and rat liver. hCE-2 exhibited different drug ester
substrate specificity from the human liver carboxylesterase called
hCE-1, which hydrolyzes the methyl ester of cocaine. hCE-2 had higher
catalytic efficiencies for hydrolysis of 4-methylumbelliferyl acetate,
heroin, and 6-monoacetylmorphine and greater inhibition by eserine than
hCE-1. hCE-2 may play an important role in the degradation of cocaine
and heroin in human tissues.
Volume 272, Number 23,
Issue of June 6, 1997
pp. 14769-14775
©1997 by The American Society for Biochemistry and Molecular Biology, Inc.
,
,
,
,
§
and
Departments of Biochemistry and Molecular
Biology and § Pathology and Laboratory Medicine, Indiana
University School of Medicine, Indianapolis, Indiana 46202-5122
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:
![]() |
E. T. Williams, K. O. Jones, G. D. Ponsler, S. M. Lowery, E. J. Perkins, S. A. Wrighton, K. J. Ruterbories, M. Kazui, and N. A. Farid The Biotransformation of Prasugrel, a New Thienopyridine Prodrug, by the Human Carboxylesterases 1 and 2 Drug Metab. Dispos., July 1, 2008; 36(7): 1227 - 1232. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. A. Schiel, S.-l. Green, W. I. Davis, P. C. Sanghani, W. F. Bosron, and S. P. Sanghani Expression and Characterization of a Human Carboxylesterase 2 Splice Variant J. Pharmacol. Exp. Ther., October 1, 2007; 323(1): 94 - 101. [Abstract] [Full Text] [PDF] |
||||
![]() |
S.-R. Kim, K. Sai, T. Tanaka-Kagawa, H. Jinno, S. Ozawa, N. Kaniwa, Y. Saito, A. Akasawa, K. Matsumoto, H. Saito, et al. Haplotypes and a Novel Defective Allele of CES2 Found in a Japanese Population Drug Metab. Dispos., October 1, 2007; 35(10): 1865 - 1872. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Tang, M. Mukundan, J. Yang, N. Charpentier, E. L. LeCluyse, C. Black, D. Yang, D. Shi, and B. Yan Antiplatelet Agents Aspirin and Clopidogrel Are Hydrolyzed by Distinct Carboxylesterases, and Clopidogrel Is Transesterificated in the Presence of Ethyl Alcohol J. Pharmacol. Exp. Ther., December 1, 2006; 319(3): 1467 - 1476. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Shi, J. Yang, D. Yang, E. L. LeCluyse, C. Black, L. You, F. Akhlaghi, and B. Yan Anti-Influenza Prodrug Oseltamivir Is Activated by Carboxylesterase Human Carboxylesterase 1, and the Activation Is Inhibited by Antiplatelet Agent Clopidogrel J. Pharmacol. Exp. Ther., December 1, 2006; 319(3): 1477 - 1484. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Imai, M. Taketani, M. Shii, M. Hosokawa, and K. Chiba Substrate Specificity of Carboxylesterase Isozymes and Their Contribution to Hydrolase Activity in Human Liver and Small Intestine Drug Metab. Dispos., October 1, 2006; 34(10): 1734 - 1741. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. C. Moffett, J. Harley, D. Francis, S. P. Sanghani, W. I. Davis, and M. J. Kuhar Maternal Separation and Handling Affects Cocaine Self-Administration in Both the Treated Pups as Adults and the Dams J. Pharmacol. Exp. Ther., June 1, 2006; 317(3): 1210 - 1218. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Kubo, S.-R. Kim, K. Sai, Y. Saito, T. Nakajima, K. Matsumoto, H. Saito, K. Shirao, N. Yamamoto, H. Minami, et al. FUNCTIONAL CHARACTERIZATION OF THREE NATURALLY OCCURRING SINGLE NUCLEOTIDE POLYMORPHISMS IN THE CES2 GENE ENCODING CARBOXYLESTERASE 2 (HCE-2) Drug Metab. Dispos., October 1, 2005; 33(10): 1482 - 1487. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Imai, M. Imoto, H. Sakamoto, and M. Hashimoto IDENTIFICATION OF ESTERASES EXPRESSED IN CACO-2 CELLS AND EFFECTS OF THEIR HYDROLYZING ACTIVITY IN PREDICTING HUMAN INTESTINAL ABSORPTION Drug Metab. Dispos., August 1, 2005; 33(8): 1185 - 1190. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Tabata, M. Katoh, S. Tokudome, M. Nakajima, and T. Yokoi IDENTIFICATION OF THE CYTOSOLIC CARBOXYLESTERASE CATALYZING THE 5'-DEOXY-5-FLUOROCYTIDINE FORMATION FROM CAPECITABINE IN HUMAN LIVER Drug Metab. Dispos., October 1, 2004; 32(10): 1103 - 1110. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Furihata, M. Hosokawa, N. Koyano, T. Nakamura, T. Satoh, and K. Chiba IDENTIFICATION OF DI-(2-ETHYLHEXYL) PHTHALATE-INDUCED CARBOXYLESTERASE 1 IN C57BL/6 MOUSE LIVER MICROSOMES: PURIFICATION, CDNA CLONING, AND BACULOVIRUS-MEDIATED EXPRESSION Drug Metab. Dispos., October 1, 2004; 32(10): 1170 - 1177. [Abstract] [Full Text] [PDF] |
||||
![]() |
Z. Sun, D. J. Murry, S. P. Sanghani, W. I. Davis, N. Y. Kedishvili, Q. Zou, T. D. Hurley, and W. F. Bosron Methylphenidate Is Stereoselectively Hydrolyzed by Human Carboxylesterase CES1A1 J. Pharmacol. Exp. Ther., August 1, 2004; 310(2): 469 - 476. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. E. Stok, H. Huang, P. D. Jones, C. E. Wheelock, C. Morisseau, and B. D. Hammock Identification, Expression, and Purification of a Pyrethroidhydrolyzing Carboxylesterase from Mouse Liver Microsomes J. Biol. Chem., July 9, 2004; 279(28): 29863 - 29869. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. P. Sanghani, S. K. Quinney, T. B. Fredenburg, W. I. Davis, D. J. Murry, and W. F. Bosron HYDROLYSIS OF IRINOTECAN AND ITS OXIDATIVE METABOLITES, 7-ETHYL-10-[4-N-(5-AMINOPENTANOIC ACID)-1-PIPERIDINO] CARBONYLOXYCAMPTOTHECIN AND 7-ETHYL-10-[4-(1-PIPERIDINO)-1-AMINO]-CARBONYLOXYCAMPTOTHECIN, BY HUMAN CARBOXYLESTERASES CES1A1, CES2, AND A NEWLY EXPRESSED CARBOXYLESTERASE ISOENZYME, CES3 Drug Metab. Dispos., May 1, 2004; 32(5): 505 - 511. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. P. Sanghani, S. K. Quinney, T. B. Fredenburg, Z. Sun, W. I. Davis, D. J. Murry, O. W. Cummings, D. E. Seitz, and W. F. Bosron Carboxylesterases Expressed in Human Colon Tumor Tissue and Their Role in CPT-11 Hydrolysis Clin. Cancer Res., October 15, 2003; 9(13): 4983 - 4991. [Abstract] [Full Text] [PDF] |
||||
![]() |
X. Zhu, N. A. Larsen, A. Basran, N. C. Bruce, and I. A. Wilson Observation of an Arsenic Adduct in an Acetyl Esterase Crystal Structure J. Biol. Chem., January 10, 2003; 278(3): 2008 - 2014. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. H. Wu, B. Yan, R. Humerickhouse, and M. E. Dolan Irinotecan Activation by Human Carboxylesterases in Colorectal Adenocarcinoma Cells Clin. Cancer Res., August 1, 2002; 8(8): 2696 - 2700. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Satoh, P. Taylor, W. F. Bosron, S. P. Sanghani, M. Hosokawa, and B. N. L. Du Current Progress on Esterases: From Molecular Structure to Function Drug Metab. Dispos., May 1, 2002; 30(5): 488 - 493. [Abstract] [Full Text] [PDF] |
||||
![]() |
S.-F. Thai, J. W. Allen, A. B. DeAngelo, M. H. George, and J. C. Fuscoe Detection of early gene expression changes by differential display in the livers of mice exposed to dichloroacetic acid Carcinogenesis, August 1, 2001; 22(8): 1317 - 1322. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Kudo, K. Umehara, M. Hosokawa, G. Miyamoto, K. Chiba, and T. Satoh Phenacetin Deacetylase Activity in Human Liver Microsomes: Distribution, Kinetics, and Chemical Inhibition and Stimulation J. Pharmacol. Exp. Ther., July 1, 2000; 294(1): 80 - 88. [Abstract] [Full Text] |
||||
![]() |
G. N. Carmona, R. A. Jufer, S. R. Goldberg, D. A. Gorelick, N. H. Greig, Q.-S. Yu, E. J. Cone, and C. W. Schindler Butyrylcholinesterase Accelerates Cocaine Metabolism: In Vitro and In Vivo Effects in Nonhuman Primates and Humans Drug Metab. Dispos., March 1, 2000; 28(3): 367 - 371. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Humerickhouse, K. Lohrbach, L. Li, W. F. Bosron, and M. E. Dolan Characterization of CPT-11 Hydrolysis by Human Liver Carboxylesterase Isoforms hCE-1 and hCE-2 Cancer Res., March 1, 2000; 60(5): 1189 - 1192. [Abstract] [Full Text] |
||||
![]() |
W. Zhu, L. Song, H. Zhang, L. Matoney, E. LeCluyse, and B. Yan Dexamethasone Differentially Regulates Expression of Carboxylesterase Genes in Humans and Rats Drug Metab. Dispos., February 1, 2000; 28(2): 186 - 191. [Abstract] [Full Text] |
||||
![]() |
J. Zhang, J. C. Burnell, N. Dumaual, and W. F. Bosron Binding and Hydrolysis of Meperidine by Human Liver Carboxylesterase hCE-1 J. Pharmacol. Exp. Ther., July 1, 1999; 290(1): 314 - 318. [Abstract] [Full Text] |
||||
![]() |
M. R. Brzezinski, B. J. Spink, R. A. Dean, C. E. Berkman, J. R. Cashman, and W. F. Bosron Human Liver Carboxylesterase hCE-1: Binding Specificity for Cocaine, Heroin, and their Metabolites and Analogs Drug Metab. Dispos., September 1, 1997; 25(9): 1089 - 1096. [Abstract] [Full Text] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |